Mark J. Spillman

A carbamazepine-indomethacin (1 : 1) cocrystal produced by milling

Mridul Majumder, Graham Buckton, Clare Frances Rawlinson-Malone et al. · CrystEngComm · 2011 · 38 citations

X-ray Crystallography, Materials Science, Medicinal Chemistry +15

Application of hydrogen-bond propensity calculations to an indomethacin–nicotinamide (1 : 1) co-crystal

Mridul Majumder, Graham Buckton, Clare Frances Rawlinson-Malone et al. · CrystEngComm · 2013 · 36 citations

Crystal Structure, Engineering, Hydrogen-bond Propensity Calculations +13

The principles underlying the use of powder diffraction data in solving pharmaceutical crystal structures

Kenneth Shankland, Mark J. Spillman, Elena A. Kabova et al. · Acta Crystallographica Section C Crystal Structure Communications · 2013 · 30 citations

X-ray Crystallography, Powder Diffraction Data, Crystal Structure +18

Salt Forms of Amides: Protonation and Polymorphism of Carbamazepine and Cytenamide

Amanda R. Buist, Alan R. Kennedy, Kenneth Shankland et al. · Crystal Growth & Design · 2013 · 21 citations

Halogenation, Molecular Pharmacology, Medicinal Chemistry +14

Co-Crystal Structures of Furosemide:Urea and Carbamazepine:Indomethacin Determined from Powder X-Ray Diffraction Data

Okba Al Rahal, Mridul Majumder, Mark J. Spillman et al. · Crystals · 2020 · 15 citations · Full text

Crystal Structure, Engineering, Organic Chemistry +17